The Penn Brain Tumor Center is nationally recognized for innovative, cutting-edge therapy of benign and malignant tumors originating in the brain, as well as metastatic cancer that originates outside of the brain.
Personalized Brain Cancer Care
The majority of newly-diagnosed brain cancers are aggressive. At the Penn Brain Tumor Center, we fight aggression with innovation. For every patient, we discuss experimental options along with standard brain tumor treatment options, in order to find the best course of action for survivorship. With cutting-edge breakthroughs such as CyberKnife, Gamma Knife, and Proton Therapy, we use precision technology to target tumors without affecting the surrounding brain tissue.
A collaborative team of Penn specialists work to develop personalized treatment plans based on their comprehensive, multidisciplinary review of all of the diagnostic information available. This includes molecular profiling, advanced neuroimaging and neurocognitive testing to select the best therapeutic options.
Penn Brain Tumor Center leadership, faculty and staff are uniquely qualified and dedicated to a single mission: from discovery to recovery, the Penn Brain Tumor Center provides a circle of exceptional care for patients with brain tumors. The center works closely with national organizations such as the American Brain Tumor Association, National Brain Tumor Society, National Cancer Institute and the NCI-sponsored Adult Brain Tumor Consortium to provide outstanding, personalized care.